產品名稱 編號 產品說明 單位 單價 加入購物車
Protein A/G磁珠 22204-1 1 mL, 10 mg/mL, 2 μm 瓶 ￥285.00
Protein A/G磁珠 22204-5 5 mL, 10 mg/mL, 2 μm 瓶 ￥1295.00
Protein A/G 免疫沉淀試劑盒 22202-20 20次反應 ￥680.00
Protein A/G 免疫沉淀試劑盒 22202-100 100次反應 ￥1980.00
Protein A 免疫沉淀試劑盒 22203-20 20次反應 ￥680.00
Protein A 免疫沉淀試劑盒 22203-100 100次反應 ￥1980.00

BeaverBeads? Protein A/G 免疫沉淀磁珠試劑盒系列產品是利用海貍生物納米表面技術，使Protein A/G 高密度定向包 被到超順磁性微球表面，與當前國際免疫磁珠市場上同類產品相比，該產品具有更多的抗體結合位點，磁珠使用量 更少，非特異性結合率低，可便捷高效地進行免疫沉淀實驗。每毫升免疫沉淀磁珠結合Human lgG的能力可達到 300μg以上，單個沉淀反應僅需50μg磁珠即可完成檢測。納米級磁珠提供的超大比表面積，大幅縮短抗體與抗原吸附 所需的平衡時間，10分鐘內即可完成抗體吸附過程，30分鐘內完成抗原沉淀操作。簡短的操作時間避免長時間操作 造成目標蛋白被水解，保證了目標蛋白的活性及蛋白復合物的完整性。 免疫沉淀磁珠試劑盒配有經過優(yōu)化的預制緩沖液，為免疫沉淀實驗提供了最佳的反應條件，提高了免疫沉淀實驗的 穩(wěn)定性。 本產品可廣泛應用于細胞裂解物、細胞分泌上清、血清、腹水等樣品中抗原的免疫沉淀反應。


產品特點

? 高效率、高產量、低消耗

? 操作靈活、簡便

? 實驗結果可靠、重復性高

? 非特異性吸附低

應用實例

BeaverBeads?  ProteinA/G與同類產品進行免疫沉淀實驗結果對比。

BeaverBeads? Protein A/G與同類產品采用多克隆、單克隆抗體進行免疫沉淀實驗結果對比。

BeaverBeads? 免疫沉淀磁珠試劑盒成功純化富集目標蛋白GST-Tag 的實驗結果。


引用文獻：


  1. MTFR2‐Mediated Fission Drives Fatty Acid and Mitochondrial Co‐Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis.Advanced Science,2025(IF:14.1)

  2. DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization.Theranostics,2025,(IF:13.3)

  3. BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING.Advanced science news,2025(IF:13.3)

  4. FBXW7/GSK3β-mediated proline-rich 11 degradation promotes oxidative DNA damage and inhibits tumor progression in renal cell carcinoma.Theranostics,2025(IF:13.3)

  5. Mechanism-guided rational design of anti-neuroinflammatory keratin-derived protein for spinal cord injury repair.Cell Biomaterials.2025(IF:12.8)

  6. CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis.Journal of Experimental & Clinical Cancer Research.,2025(IF:11.16)

  7. Excision Repair Cross Complementation Group 1 gene exon 3 skip** isoform presents selective cGAS-STING activation in Platinum-sensitive lung adenocarcinoma.Free Radical Biology and Medicine.2025(IF:8.2)

  8. Cutin formation in tomato is controlled by a multipartite module of synergistic and antagonistic transcription factors.Cell Reports.2025,(IF:6.9)

  9. Liu J, Luo Y, Chen S, et al. Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT[J]. Advanced Science, 2024, 11(45): 2403995.(IF:14.3)

  10. Lu J, Li N, Li G, et al. N-glycosylation of SnRK2s affects NADPH maintenance in peroxisomes during prolonged ABA signalling[J]. Nature Communications, 2024, 15(1): 6630.(IF:14.7)

  11. Fu W, Lin Y, Bai M, et al. Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing[J]. Acta Pharmaceutica Sinica B, 2024, 14(9): 3931-3948.(IF:14.7)

  12. Li X, Chen X, Yang F, et al. Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction[J]. Journal of Advanced Research, 2024.(IF:11.4)

  13. Protective effect of hydrogen sulfide on TNF-a and IFN-c-induced injury of intestinal epithelial barrier function in Caco-2 monolayers；Pharmacological research    出版年: 2016-Nov-10 (Epub 2016 Nov 10)

  14. 樹鼩IgG純化鑒定及其多克隆抗體制備和檢測； 現(xiàn)代生物醫(yī)學進展

  15. 血管性血友病因子裂解酶(ADAMTS13)單克隆抗體的鑒定以及生物學功能的研究；中國實驗血液學雜志

  16. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity；Oncogene (2017) 36, 6391–6407，DOI:10.1038/onc.2017.241



    暫無視頻